Research and experimental development on natural sciences and engineering
MIZAR BIO AS
Revenue 2025
NOK 681,000
Operating profit
NOK 370,000
Equity
NOK 974,000
Incorporated
2016
Share capital
NOK 240,000
Key figures · 2025
Current ratio
8.83
Equity ratio
88.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 54.4% | |
| Net margin (%%) | -94.6% | |
| Return on assets (%%) | 33.7% | |
| Likviditet | ||
| Current ratio | 8.83 | |
| Working capital | 974k | |
| Soliditet | ||
| Equity ratio (%%) | 88.7% | |
| Debt-to-equity ratio | 0.13 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.